{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:32:15Z","timestamp":1778693535661,"version":"3.51.4"},"reference-count":32,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS069616, NS081426"],"award-info":[{"award-number":["NS069616, NS081426"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2016.00047","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T09:50:21Z","timestamp":1459245021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?"],"prefix":"10.3389","volume":"7","author":[{"given":"Sabrina K.","family":"Hollinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ike S.","family":"Okosun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie S.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"issue":"Suppl 1","key":"B1","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1080\/14660820052415899","article-title":"Genetic factors in the early diagnosis of ALS","volume":"1","author":"Andersen","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"3\u20134","key":"B2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/21678421.2014.990036","article-title":"Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients","volume":"16","author":"Watanabe","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3\u20134","key":"B3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/21678421.2014.993650","article-title":"The predictors of survival in Chinese amyotrophic lateral sclerosis patients","volume":"16","author":"Wei","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"B4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/17482960701278562","article-title":"Disease progression and survival in ALS: first multi-state model approach","volume":"8","author":"Gil","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"issue":"6","key":"B5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3109\/17482968.2010.482592","article-title":"A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS","volume":"11","author":"Jawaid","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"issue":"5","key":"B6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000433581","article-title":"An assessment of possible neuropathology and clinical relationships in 46 sporadic amyotrophic lateral sclerosis patient autopsies","volume":"15","author":"Coan","year":"2015","journal-title":"Neurodegener Dis"},{"issue":"9","key":"B7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1136\/jnnp-2012-304724","article-title":"Lifetime physical activity and the risk of amyotrophic lateral sclerosis","volume":"84","author":"Huisman","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/jnnp-2013-304935","article-title":"Increased premorbid physical activity and amyotrophic lateral sclerosis: born to run rather than run to death, or a seductive myth?","volume":"84","author":"Turner","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"B9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/ene.12015","article-title":"Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis","volume":"20","author":"Korner","year":"2013","journal-title":"Eur J Neurol"},{"issue":"11","key":"B10","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/ene.12632","article-title":"Association between diabetes and amyotrophic lateral sclerosis in Sweden","volume":"22","author":"Mariosa","year":"2015","journal-title":"Eur J Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000369812","article-title":"Antecedent disease is less prevalent in amyotrophic lateral sclerosis","volume":"15","author":"Mitchell","year":"2015","journal-title":"Neurodegenerative Dis"},{"issue":"5","key":"B12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1468-1331.2009.02923.x","article-title":"ALS disease onset may occur later in patients with pre-morbid diabetes mellitus","volume":"17","author":"Jawaid","year":"2010","journal-title":"Eur J Neurol"},{"issue":"6","key":"B13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1179\/1743132812Y.0000000049","article-title":"Is hyperlipidemia correlated with longer survival in patients with amyotrophic lateral sclerosis?","volume":"34","author":"Dedic","year":"2012","journal-title":"Neurol Res"},{"issue":"6","key":"B14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1177\/1352458511427719","article-title":"Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?","volume":"18","author":"Etemadifar","year":"2012","journal-title":"Mult Scler"},{"issue":"9","key":"B15","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00415-012-6440-7","article-title":"Uric acid levels predict survival in men with amyotrophic lateral sclerosis","volume":"259","author":"Paganoni","year":"2012","journal-title":"J Neurol"},{"issue":"4","key":"B16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","article-title":"Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis","volume":"258","author":"Dorst","year":"2011","journal-title":"J Neurol"},{"issue":"2","key":"B17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/17482968.2011.610110","article-title":"Modifying effect of arterial hypertension on amyotrophic lateral sclerosis","volume":"13","author":"Moreau","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"issue":"1","key":"B18","first-page":"A56","article-title":"Biocuration for undergraduates: developing tomorrow\u2019s researchers while mining today\u2019s data","volume":"14","author":"Mitchell","year":"2015","journal-title":"J Undergrad Neurosci Educ"},{"issue":"6","key":"B19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","article-title":"Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis","volume":"82","author":"Sutedja","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"B20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mus.22114","article-title":"Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis","volume":"44","author":"Paganoni","year":"2011","journal-title":"Muscle Nerve"},{"issue":"9","key":"B22","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1111\/ene.12729","article-title":"Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis","volume":"22","author":"Elia","year":"2015","journal-title":"Eur J Neurol"},{"issue":"4","key":"B23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/17482968.2012.678366","article-title":"Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan","volume":"13","author":"Shimizu","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"issue":"3","key":"B24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/21678421.2012.735240","article-title":"Premorbid body mass index and risk of amyotrophic lateral sclerosis","volume":"14","author":"O\u2019Reilly","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"10","key":"B25","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/jamaneurol.2015.1584","article-title":"Effect of presymptomatic body mass index and consumption of fat and alcohol on amyotrophic lateral sclerosis","volume":"72","author":"Huisman","year":"2015","journal-title":"JAMA Neurol"},{"issue":"6060","key":"B26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1126\/science.1213775","article-title":"Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes","volume":"334","author":"Cyrklaff","year":"2011","journal-title":"Science"},{"issue":"3","key":"B27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1152\/jn.00592.2010","article-title":"The dynamics of somatic input processing in spinal motoneurons in vivo","volume":"105","author":"Mitchell","year":"2011","journal-title":"J Neurophysiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jtbi.2012.01.019","article-title":"Cargo distributions differentiate pathological axonal transport impairments","volume":"300","author":"Mitchell","year":"2012","journal-title":"J Theor Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fncel.2015.00248","article-title":"Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A amyotrophic lateral sclerosis mice","volume":"9","author":"Irvin","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fncel.2015.00462","article-title":"Type I vs. Type II cytokine levels as a function of SOD1 G93A mouse amyotrophic lateral sclerosis disease progression","volume":"9","author":"Jeyachandran","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B31","first-page":"59","article-title":"Dynamic meta-analysis as a therapeutic prediction tool for amyotrophic lateral sclerosis","volume-title":"Amyotrophic Lateral Sclerosis","author":"Mitchell","year":"2012"},{"issue":"1\u20132","key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/21678421.2015.1047455","article-title":"State of the field: an informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model","volume":"17","author":"Kim","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"}],"container-title":["Frontiers in Neurology"],"original-title":[],"deposited":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T16:22:35Z","timestamp":1459959755000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fneur.2016.00047\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3389\/fneur.2016.00047","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}